Genmab A/S: Genmab Announces Multiple Abstracts to be Presen

Poster presentations highlighting safety and preliminary efficacy data of epcoritamab (DuoBody-CD3xCD20) in combination with other treatments in patients with B-cell non-Hodgkin lymphoma (NHL)

Related Keywords

Japan , Tokyo , United States , Netherlands , Denmark , Copenhagen , Køavn , New Jersey , American , Marisol Peron , Genmab Duobody , Andrew Carlsen , Exposition Of The American Society Hematology , Janssen Biotech Inc , Twitter , Drug Administration , Georgia World Congress Center , Macrophage Properties Journal Of Immunology Baltimore , Exchange Commission , Us National Library Of Medicine , Development Of Novel Anti , Global Investor Relations Communications , Annual Meeting , American Society , Janssen Biotech , Chief Executive Officer , Preliminary Results , Refractory Follicular Lymphoma , Refractory Chronic Lymphocytic Leukemia , Refractory Diffuse Largeb Cell Lymphoma , Transplant Eligible Patients , Newly Diagnosed Multiple Myeloma , Minimal Residual Disease , Dexamethasone Based , Lenalidomide Starting Dose , Impaired Renal Function From , Daratumumab With Bortezomib , Patients With Newly Diagnosed Light Chain , Landmark Analysis , Dexamethasone With , Without Subcutaneous Daratumumab , Patients With Relapsed , Refractory Multiple Myeloma , Updated Analysis , Rapid Corticosteroid Tapering , Refractory Multiple Myeloma Patients , Survival Outcomes , Response Status , Prednisone With , Without Daratumumab , Pooled Subgroup Analysis , Prednisone Versus Bortezomib , Transplant Ineligible Patients , Pooled Analysis , Media Release , Annual Report , Y Shaped Genmab , Clinically Utilized , Directed Antibodies , Macrophage Properties , Novel Anti Cd , Cell Surface , Cancer Science , Product Characteristics , Senior Vice President , Investor Relations , Vice President , Genmab , Nnounces , Multiple , Abstracts , Resented , 3rd , Nnual , Meeting , Exposition , Society , Hematology ,